Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China · Delayed Price · Currency is CNY 12.85
+0.19 (1.50%)
Jun 9, 2026, 3:04 PM CST
SHE:002755 Market Cap
SHE:002755 has a market cap or net worth of 11.75 billion as of June 9, 2026. Its market cap has decreased by -26.44% in one year.
Market Cap
11.75B
Enterprise Value
9.35B
Revenue
1.75B
Ranking
n/a
PE Ratio
45.30
Stock Price
12.85
Market Cap Chart
Since January 2, 2019, SHE:002755's market cap has increased from 9.84B to 11.75B, an increase of 19.44%. That is a compound annual growth rate of 2.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 11.75B | -22.47% |
| Dec 31, 2025 | 15.16B | 28.48% |
| Dec 31, 2024 | 11.80B | 17.47% |
| Dec 29, 2023 | 10.04B | 36.27% |
| Dec 30, 2022 | 7.37B | -37.63% |
| Dec 31, 2021 | 11.82B | -2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 12.98B |
| Shenzhen Hepalink Pharmaceutical Group | 12.79B |
| Guobang Pharma | 12.44B |
| Henan Lingrui Pharmaceutical | 12.25B |
| Shanghai Shyndec Pharmaceutical | 12.02B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.98B |
| Zhejiang Medicine | 11.54B |
| Hubei Hongyuan Pharmaceutical Technology | 11.43B |